223
Views
12
CrossRef citations to date
0
Altmetric
Reports

A retrospective analysis of the clinical efficacies and recurrence of Q-switched Nd:YAG laser treatment of nevus of Ota in 224 Chinese patients

, , , &
Pages 410-414 | Received 16 Aug 2017, Accepted 20 Feb 2018, Published online: 09 Mar 2018

References

  • Rabinovitz HS, Barnhill RL. Benign melanocytic neoplasms. In: Dermatology (Bolognia JL, Jorizzo JL, Schaffer JV). 3rded. London: Elsevier Saunders; 2012. p. 1858–59.
  • Saha A, Bandyopadhyay D. Nevus of ota. Indian Pediatr. 2014;51:510.
  • Zhang Q, Tan C, Jiang P, Yang G. Clinical profile and triggering factors for acquired, bilateral nevus of Ota-like macules. Cutan Ocul Toxicol. 2017;25:1–14.
  • Suh DH, Hwang JH, Lee HS, Youn JI, Kim PM. Clinical features of Ota’s naevus in Koreans and its treatment with Q-switched alexandrite laser. Clin Exp Dermatol. 2000;25:269–73.
  • Chang CJ, Nelson JS, Achauer BM. Q-Switiched ruby laser of oculodermal melanosis (Nevus of Ota). Plast Reconstr Surg. 1996;98:784–90.
  • Tse Y, Levine VJ, Mcclain SA, Ashinoff R. The removal of cutaneous pigmented lesions with the Q-switched neodymium: yttrium-aluminum-garnetlaser. J Dermatol Surg Oncol. 1994;20:795–800.
  • Ota M, Tamino H. A variety of nevus frequently encountered in Japan, nevus usco-caeruleus ophthalmomaxillaris and its relation to pigmentary change in the eye. Tokyo Med J. 1939;63:1242–44.
  • Redkar NN, Rawat KJ, Warrier S, Jena A. Nevus of Ota. J Assoc Physicians India. 2016;64:76–88.
  • Liu J, Ma YP, Ma XG, Chen JZ, Sun Y, Xu HH, Gao XH, Chen HD, Li YH. A retrospective study of q-switched alexandrite laser in treating nevus of Ota. Dermatol Surg. 2011;37:1480–85.
  • Seo HM, Choi CW, Kim WS. Beneficial effects of early treatment of nevus of Ota with low-fluence 1,064-nm Q-switched Nd: YAGlaser. Dermatol Surg. 2015;41:142–48.
  • Choi JE, Lee JB, Park KB, Kim BS, Yeo UC, Huh CH, Kim JH, Kye YC. A retrospective analysis of the clinical efficacies of Q-switched Alexandrite and Q-switched Nd: YAGlasers in the treatment of nevus of Ota in Korean patients. J Dermatol Treat. 2015;26:240–45.
  • Shah VV, Bray FN, Aldahan AS, Mlacker S, Nouri K. Lasers and nevus of Ota: a comprehensive review. Lasers Med Sci. 2016;31:179–85.
  • Lowe NJ, Wieder JM, Sawcer D, Burrows P, Chalet M. Nevus of Ota: treatment with high energy fluences of the Qswitche ruby laser. J Am Acad Dermatol. 1993;29:997–1001.
  • Yu P, Yu N, Diao W, Yang X, Feng Y, Qi Z. Comparison of clinical efficacy and complications between Q-switched alexandrite laser and Q-switched Nd: YAGlaser on nevus of Ota: a systematic review and meta-analysis. Lasers Med Sci. 2016;31:581–91.
  • Sami L, Changzheng H, Yan L. Factors affecting response, number of laser sessions and complications in nevus of Ota treated by Q-switched alexandrite laser: a retrospective study. G Ital Dermatol Venereol. 2016;151:160–68.
  • Lee HS, Kim M, Kang HY. Recurrence of nevus of Ota after successful laser treatment: possible role of dermal stemcells. Ann Dermatol. 2016;28:647–49.
  • Li L, Fukunaga-Kalabis M, Yu H, Xu X, Kong J, Lee JT, Herlyn M. Human dermal stem cells differentiate into functional epidermal melanocytes. J Cell Sci. 2010;123:853–60.
  • Zabierowski SE, Fukunaga-Kalabis M, Li L, Herlyn M. Dermisderived stem cells: a source of epidermal melanocytes and melanoma? Pigment Cell Melanoma Res. 2011;24:422–29.
  • Kono T, Nozaki M, Chan HH, Mikashima Y. A retrospective study looking at the long-term complications of Q-switched ruby laser in the treatment of nevus ofOta. Lasers Surg Med. 2001;29:156–59.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.